Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV  or hepatitis B/C infection

We examined the safety outcomes of these populations treated with anti-PD-1/PD-L1 treatment in a multicentre retrospective study.

Source: European Journal of Cancer - October 20, 2018 Category: Cancer & Oncology Authors: Martin Tio, Rajat Rai, Ogochukwu M. Ezeoke, Jennifer L. McQuade, Lisa Zimmer, Chloe Khoo, John J. Park, Lavinia Spain, Samra Turajlic, Luke Ardolino, Desmond Yip, Simone M. Goldinger, Justine V. Cohen, Michael Millward, Victoria Atkinson, Alisa Y. Kane, P Tags: Original Research Source Type: research